MedPath
HSA Approval

BEACTAFED SYRUP

SIN03143P

BEACTAFED SYRUP

BEACTAFED SYRUP

June 7, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R01BA52

pseudoephedrine, combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

PSEUDOEPHEDRINE HCl

32 mg/5 ml

Pseudoephedrine

TRIPROLIDINE HCl

1.25 mg/5 ml

Triprolidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEACTAFED SYRUP - HSA Approval | MedPath